Does GLEEVEC Cause Malignant neoplasm progression? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Malignant neoplasm progression have been filed in association with GLEEVEC. This represents 4.5% of all adverse event reports for GLEEVEC.
12
Reports of Malignant neoplasm progression with GLEEVEC
4.5%
of all GLEEVEC reports
4
Deaths
8
Hospitalizations
How Dangerous Is Malignant neoplasm progression From GLEEVEC?
Of the 12 reports, 4 (33.3%) resulted in death, 8 (66.7%) required hospitalization, and 1 (8.3%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLEEVEC. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does GLEEVEC Cause?
Death (72)
Nausea (26)
Diarrhoea (24)
Fatigue (23)
Vomiting (23)
Fall (20)
Muscle spasms (18)
Asthenia (15)
Malaise (15)
Rash (14)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which GLEEVEC Alternatives Have Lower Malignant neoplasm progression Risk?
GLEEVEC vs GLICLAZIDE
GLEEVEC vs GLIMEPIRIDE
GLEEVEC vs GLIMEPIRIDE\ROSIGLITAZONE
GLEEVEC vs GLIPIZIDE
GLEEVEC vs GLIVEC